(NASDAQ: TNDM) Tandem Diabetes Care's forecast annual revenue growth rate of 6.89% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Tandem Diabetes Care's revenue in 2025 is $1,007,001,000.On average, 27 Wall Street analysts forecast TNDM's revenue for 2025 to be $69,226,208,539, with the lowest TNDM revenue forecast at $66,166,288,077, and the highest TNDM revenue forecast at $71,667,093,463. On average, 27 Wall Street analysts forecast TNDM's revenue for 2026 to be $76,277,653,875, with the lowest TNDM revenue forecast at $70,921,267,514, and the highest TNDM revenue forecast at $80,956,016,646.
In 2027, TNDM is forecast to generate $83,396,901,570 in revenue, with the lowest revenue forecast at $76,481,060,952 and the highest revenue forecast at $89,566,916,239.